U.S. Capital Wealth Advisors, LLC Gsk PLC Transaction History

U.S. Capital Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $332,447 - $377,669	7,906 Added 3.51%	233,403 $10.2 Million
Q1 2022 May 12, 2022	BUY	$40.23 - $47.74 $791,645 - $939,427	19,678 Added 9.56%	225,497 $9.82 Million
Q4 2021 Jan 21, 2022	BUY	$38.88 - $45.31 $223,754 - $260,759	5,755 Added 2.88%	205,819 $9.08 Million
Q3 2021 Nov 01, 2021	BUY	$38.79 - $43.16 $7.76 Million - $8.63 Million	200,064 New	200,064 $7.64 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.